2009 Abstract Submission Program
The 2009 Abstract Submission Program will be available in early September. The deadline to submit an abstract for the 2009 Annual Meeting in Seattle will be November 3, 2008.
Science at the Annual Meeting
The AAN Annual Meeting brings together more than 10,000 neuroscience professionals for one of the world's largest neurology gatherings. It has long been a leading showcase for the latest developments in scientific research, and the place to honor peers at the forefront of the work.
Science Press Releases from the AAN
Late-Breaking Science
Late-Breaking science abstracts were recently presented at the 2008 Annual Meeting in Chicago, IL. Click here to view a list of accepted abstracts.
2008 Plenary Session Presentations
| Presidential Lecture | Giancomo Rizzolatti, MD - "The Mirror Neuron System" |
| Robert Wartenberg Lecture | Robert L. MacDonald, MD, PhD, MD - "Molecular Pathogenesis of Genetic Epilepsies Associated with GABAA Receptor Mutations" |
| George C. Cotzias Lecture | Arnold R. Kriegstein, MD, PhD - "The Dynamics of Neural Stem and Progenitor Cells in Cortical Development" |
| Sidney Carter Award in Child Neurology | Marjo van der Knaap, MD, PhD - "Leukoencephalopathies: From MRI Patterns to Disease Genes and Beyond" |
| Frontiers in Clinical Neuroscience | Moses Rodriguez, MD - "Natural Autoantibodies in the Treatment of Neurological Disease"
Kristine Yaffe, MD - "Prevention of Dementia in 2008: Strategies from Epidemiological Studies" Harry T. Orr, PhD - "Protein Interactions and Cell Signaling Pathways in SCA1 Pathogenesis: Targets for Therapeutics" Ann M. Graybiel, PhD - "Learning and Memory Mechanisms of the Basal Ganglia" |
| Hot Topics | Jose B. Cibelli, DVM, MD - "Embryonic Stem Cells with no Embryos"
D. James Surmeir, PhD - "Calcium and Neurodegeneration in Parkinson?s Disease" Jeffrey H. Kordower, PhD - "Animals Activists? Activity and their Effect on Neuroscience Research: What Investigators Need to Know to Protect Themselves" John W. Krakauer, MD - "Constraint-Induced Movement Therapy: What is it Doing?" |
| Contemporary Clinical Issues | Michael D. Kaufman, MD - "A Phase 2 Randomized, Double-Blinded, Placebo-Controlled, Multi-Center Study of Subcutaneous Daclizumab, a Humanized Anti-CD-25 Monoclonal Antibody in Patients with Active, Relapsing Forms of Multiple Sclerosis?Week 4 Results"
Robert H. Baloh, MD, PhD - "TDP-43 Mutation in Familial Motor Neuron Disease" James A. Russell, DO - "Sedation for the Imminently Dying: Survey Results from the AAN Ethics Section" |
| Contemporary Clinical Issues Case Studies | Patrick Y. Wen, MD - "Novel Antiangiogenic Therapy in Neuro-Oncology"
Juliane Winkelmann, MD - "Restless Legs Syndrome: New Perspectives" Marc I. Chimowitz, MD - "Symptomatic Intracranial Arterial Stenosis: Is Stenting Ready for Prime Time?" |
